Adrenoleukodystrophy Drugs Market Size, Trends, Shares, Insights and Forecast – 2020-2027

1. ADRENOLEUKODYSTROPHY DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Adrenoleukodystrophy Drugs Market - Overview Global AdrenoleukodystrophyDrugs Market Regional Analysis On basis of regions, the global Adrenoleukodystrophy Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In North America, pharmaceutical companies are focusing on advancement of therapies for treatment of adrenoleukodystrophy. Adrenoleukodystrophy (ALD) is a rare genetic disorder linked with the X chromosome in males and females. Adrenoleukodystrophy (ALD) causes mutation of the ABCD1 gene in individuals which elevates ALD proteins. These proteins are used to clear toxic molecules known as saturated very long chain fatty acids. Thus accumulation of saturated very long chain fatty acid in tissue throughout the body leads to damage of myelin, thus causing neurological problems in patients. Adrenoleukodystrophy (ALD) is most commonly observed in childhood and present in both males and females. Adrenoleukodystrophy (ALD) is further identified by its phenotypes such as childhood onset of ALD, Addison disease, adrenomyeloneuropathy and diagnosed with the help of blood testing, magnetic resonance imaging, vision screening, skin biopsy and fibroblast cell culture. Treatment used for Adrenoleukodystrophy (ALD) are stem cell transplant, adrenal insufficiency treatment, gene therapy and dietary therapy. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/adrenoleukodystrophy-drugs-market-4162 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global AdrenoleukodystrophyDrugs Market: Drivers Adrenoleukodystrophy is a rare genetic disorder which is characterized by symptoms such as childhood onset of ALD, Addison disease, and adrenomyeloneuropathy. Therefore, depending upon symptoms, the type of an adrenoleukodystrophy drug have to be evaluated and treatment need to be prescribed accordingly. For instance, in May 2020, SwanBio Therapeutics, a developer of biological therapeutics, announced that they have raised US$ 52 million for advancement of their viral base gene therapy for adrenomyeloneuropathy. Funds were raised with the help of series A financing round. These factors are expected to drive growth of the global adrenoleukodystrophy drugs market. Global AdrenoleukodystrophyDrugs Market: COVID-19 Impact Analysis COVID-19 adrenoleukodystrophy drugs market, adrenoleukodystrophy patients are facing challenges due to reallocation of neurological intensive beds and neurological wards to COVID-19 patients. As a result, there is difficulty in management of emergencies related to neurological disorders. Furthermore, implementation of lockdowns governments of various countries have affected the supply chain activities, and led to a shortage in inventories of pharmaceutical companies. has affected several markets around the world. In case of global and restrictions on transportation by These factors are expected to restrain the global adrenoleukodystrophy drugs market growth Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4162 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Global Adrenoleukodystrophy Drugs Market: Restraints Stem cell transplant is a treatment used for Adrenoleukodystrophy, but causes side effects such as interstitial pneumonia, liver damage and mucositis. Moreover, in adrenal insufficiency treatment, hydrocortisone is a major drug which affects cortisol levels in adrenoleukodystrophy patients and also weakens the immune system. Furthermore, gene therapy may lead to mutation of cells and inflammation due to wrong incorporation of DNA on DNA locations. In 2018, Europe PMC claimed that adrenal insufficiency is a life threating condition with mortality rate of 0.5 in 100 patients per year. Moreover, pharmaceutical companies are focusing on research and development of treatments for adrenoleukodystrophy to strengthen their share in the global adrenoleukodystrophy drugs market. For instance, in January 2020, Minoryx Therapeutics, a company specialised in innovation of drugs for central nervous system conditions, received an approval for lead drug candidate, leriglitazone (MIN-102), for treatment of all forms of x- adrenoleukodystrophy. Global Adrenoleukodystrophy Drugs Market: Key Players Key operating players in global adrenoleukodystrophy drugs market are Applied Genetic Technologies Corporation, MedDay SA, Bluebird bio, Inc., Minoryx Therapeutics S.L, ReceptoPharm Inc., Pfizer Inc., SOM Innovation Biotech, S.A, SwanBio Therapeutics and Viking Therapeutics, Inc. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4162 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved